The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma
Blood and Lymphatic Cancer: Targets and Therapy · 2019
DOI: 10.2147/blctt.s177009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Blood and Lymphatic Cancer: Targets and Therapy, 2019. Verfasst von Michael Schieber und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern Unive…. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
Zitieren
APA
Schieber, M., & Ma, S. (2019). The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma. Blood and Lymphatic Cancer: Targets and Therapy. https://doi.org/10.2147/blctt.s177009
Vancouver
Schieber M, Ma S. The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma. Blood and Lymphatic Cancer: Targets and Therapy. 2019. doi:10.2147/blctt.s177009
BibTeX
@article{Schieber2019,
author = {Schieber, Michael and Ma, Shuo},
title = {The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma},
journal = {Blood and Lymphatic Cancer: Targets and Therapy},
year = {2019},
doi = {10.2147/blctt.s177009}
}
EUVIMED